4th Annual Pharmacovigilance & Risk Management Strategies Summit
26-27

April 2018

Austria

Vienna

Austria Trend Parkhotel Schönbrunn

Hietzinger Hauptstraße 10-16, 1130

About

Vonlanthen Group is pleased to invite you to the ‘4th Annual Pharmacovigilance & Risk Management Strategies Summit’ scheduled for April 26th – 27th, 2018 in Vienna, Austria. Pharmacovigilance (PV) is taking on a new form and landscape in the 21st century. Many different factors are moulding and shaping the terrain through regulations, collaborations, and countries standardising regulations to meet global compliance. Along with the rapid digital revolution unfolding throughout pharma, it is high time of change for those in regulatory affairs an...

Vonlanthen Group is pleased to invite you to the ‘4th Annual Pharmacovigilance & Risk Management Strategies Summit’ scheduled for April 26th – 27th, 2018 in Vienna, Austria. Pharmacovigilance (PV) is taking on a new form and landscape in the 21st century. Many different factors are moulding and shaping the terrain through regulations, collaborations, and countries standardising regulations to meet global compliance. Along with the rapid digital revolution unfolding throughout pharma, it is high time of change for those in regulatory affairs and research. We will be taking two days to discover insights from top professionals leading the transformation in PV. These industry leaders will deliver the latest developments in regulation, collaborations, and detections methods. Moreover, they will describe how to overcome digital challenges with solid solutions for all those in the field of drug safety at our Vienna Summit. It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you at the Summit in Vienna in April!

more info
Who Should Attend

Chief Executives, Directors, Vice Presidents, Heads, Leaders, Senior Managers, Scientists, Chemists, Engineers and Fellows specialising in:

  • Pharmacovigilance
  • Product Safety
  • RMPs
  • Safety Surveillance
  • Drug Development
  • Drug Safety
  • Risk Management
  • Safety Management
  • Patient Safety
  • QPPV

For Pharmacovigilance QPPV:

  • GVP
  • PV Inspection & Audit
  • Signal Detection
  • Clinical Development
  • Safety Databases
  • Regulatory Affairs
  • Clinical Research
  • Quality Assurance
  • Pharmacoepidemiology
  • Health Outcomes
  • Clinical Data Management
  • PV Agreements
  • PSMF
  • Medical Affairs
  • ICH-GCP
  • Signal Management
  • Clinical Trials
  • Safety Evaluation
  • Medical Product Safety Assessment
  • Regulatory Submissions
  • Assurance & Compliance
  • Data Analysis
  • Medical Information
  • PSUR/PBRER
  • MedDRA
  • PASS/PAES
  • Compliance
  • Adverse Drug Reactions - ADR
Key Practical Learning Points of the Summit

Global regulatory safety updates
Digital mechanisms and implementations
Latest innovations and trends in PV
Risk management planning and remediation strategies
Potentials and best practices in signal management
Pharmacovigilance (PV) and data management
Social media and digital technologies
Collaborative progression and advancement in research
Speakers
Dr. Susan Welsh, US

Chief Safety Officer

CSL Behring

Dr. Doris Irene Stenver, DK

Chief Medical Officer

Danish Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee Delegate

Diane E. Beck, US

Vice President & Head of Global Pharmacovigilance Services

Takeda

Dr. Julia Appelskog, SE

Head of Pharmacovigilance Strategy Office

Merck

Dr. Phillip Eichorn, UK

Senior Director

Pfizer

Olga Kuhlmann, DE

Head PV Audits, Inspections & Training Strategy

Boehringer Ingelheim International

Ricarda Tiemeyer, CH

Head of Drug Safety & PoC Medical Information

Roche Pharma (Schweiz) AG

Marie-Laure Kürzinger, FR

Pharmacoepidemiologist / Epidemiology & Benefit Risk Evaluation

Sanofi

Dr. Nicole Lang, DE

Senior Director, PhV TA Group Leader, Biologics, Respiratory & IM

Teva, Global Patient Safety & Pharmacovigilance

Dr. Mircea Ciuca, CH

Head Medical and Clinical Drug Safety

Vifor Pharma

Dr. Pavel Vaclavik, AT

Senior Manager, PV Technology Data Management Global Patient Safety

Baxter International Inc.

Dr. Jackie Roberts, UK

Executive Director Regulatory, Pharmacovigilance & Medical

Accord Healthcare Ltd.

Mariana Almas, UK

Associate Epidemiologist

IQVIA (formerly QuintilesIMS)

Dr. Jiri Juchelka, CZ

Medical Director

PAREXEL International

Dr. Elizabeth Ursell, UK

Director, Pharmacovigilance

Mapi Life Sciences

Annual

Events

Previous Year Attendees
  • uniQure biopharma B.V. The Netherlands

    Pharmacovigilance Drug Safety Expert

  • Biotest AG Germany

    Corporate Drug Safety - Operations

  • PharmaLex GmbH Germany

    Global Head Pharmacovigilance

  • Läkemedelsverket Medical Products Agency Sweden

    Pharmacovigilance Inspector

  • Berlin-Chemie AG Germany

    Medical Assessor, Quality Assurance Manager

  • Zwiers Regulatory Consultancy B.V. The Netherlands

    QPPV

  • PharmaLex GmbH Germany

    Manager Pharmacovigilance

  • KRKA Slovenia

    Senior QA Associate

  • Sanofi Aventis Groupe France

    ITS Project Leader

  • PrimeVigilance Limited UK

    Director Global Pharmacovigilance Operations

  • G. Pohl-Boskamp GmbH & Co. KG Germany

    Director Pharmacovigilance

  • CureVac AG Germany

    Associate Medical Director

  • VISUfarma S.p.A. Italy

    Deputy QPPV and Regulatory Affairs Specialist

  • DBV Technologies France

    Drug Safety Pharmacist



more info
Sponsors and Partners

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner